Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fule Tablets (妇乐片) is a Traditional Chinese Medicine (TCM) product developed and manufactured by Shaanxi Dongtai Pharmaceutical. It is an oral herbal formulation composed of several botanical ingredients, including *Lonicerae Japonicae Caulis* (忍冬藤), *Isatidis Folium* (大青叶), *Taraxaci Herba* (蒲公英), *Moutan Cortex* (牡丹皮), *Paeoniae Radix Rubra* (赤芍), *Chuanxiong Rhizoma* (川芎), *Corydalis Rhizoma* (延胡索), and *Glycyrrhizae Radix et Rhizoma* (甘草). The drug is primarily used to treat gynecological disorders characterized by heat-toxin and blood stasis in TCM theory. Its clinical indications include pelvic inflammatory disease (PID), endometritis, and adnexitis, as well as associated uterine bleeding (子宫出血). The therapeutic effects are attributed to its anti-inflammatory, analgesic, and blood-cooling properties, which help regulate menstruation and alleviate pelvic pain and abnormal discharge.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fule Tablets.